[{"notes_id":"1_1182","category":"1","subcategory":"1","title":"Atrial fibrillation: rate control and maintenance of sinus rhythm","body":"NICE updated its guidelines on the management of atrial fibrillation (AF) in 2021. The following is also based on the joint American Heart Association (AHA), American College of Cardiology (ACC) and European Society of Cardiology (ESC) 2012 guidelines<br \/><br \/><h5 class='notes-heading'>Patients presenting acutely with AF<\/h5><br \/>If a patient has signs of haemodynamic instability (e.g. hypotension, heart failure) they should be <span class=\"concept\" data-cid=\"11783\">electrically cardioverted<\/span>, as per the peri-arrest tachycardia guidelines.<br \/><br \/>For haemodynamically stable patients, the management depends on how acute the AF is:<br \/><ul><li>< 48 hours:  rate or rhythm control<\/li><li><span class=\"concept\" data-cid=\"11784\">\u2265 48 hours or uncertain (e.g. patient not sure when symptoms started): rate control<\/span><ul><li>if considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a <span class=\"concept\" data-cid=\"11785\">minimum of 3 weeks<\/span><\/li><\/ul><\/li><li>anticoagulation<ul><li><span class=\"concept\" data-cid=\"12390\">all patients with new-onset AF require anticoagulation, regardless of onset<\/span><\/li><li>long-term anticoagulation is based on the CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc score<\/li><\/ul><\/li><\/ul><br \/><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/ecg088b.png\" data-fancybox=\"gallery\" data-caption=\"Atrial fibrillation - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/ecg088.png\" alt=\"\" \/><\/a><\/div><\/div><\/div><br \/><h5 class='notes-heading'>Rate control<\/h5><br \/>Rate control should be offered as the first-line treatment strategy for atrial fibrillation except in people:<br \/><ul><li>whose atrial fibrillation has a reversible cause<\/li><li>who have heart failure thought to be primarily caused by atrial fibrillation<\/li><li>with new-onset atrial fibrillation (< 48 hours)<\/li><li>with atrial flutter whose condition is considered suitable for an ablation strategy to restore sinus rhythm<\/li><li>for whom a rhythm-control strategy would be more suitable based on clinical judgement<\/li><\/ul><br \/><h6 class='notes-subheading'>Medications<\/h6><br \/>Agents used to control rate in patients with atrial fibrillation<br \/><ul><li><span class=\"concept\" data-cid=\"200\">beta-blockers<\/span><ul><li><span class=\"concept\" data-cid=\"10829\">a common contraindication for beta-blockers is asthma<\/span><\/li><\/ul><\/li><li>calcium channel blockers<\/li><li><span class=\"concept\" data-cid=\"3135\">digoxin<\/span><ul><li>not considered first-line anymore as they are less effective at controlling the heart rate during exercise<\/li><li>should only be considered if the person does no or very little physical exercise or other rate-limiting drug options are ruled out because of comorbidities <\/li><li>may have a role if there is coexistent heart failure<\/li><\/ul><\/li><\/ul><br \/><h5 class='notes-heading'>Rhythm control<\/h5><br \/>Agents used to maintain sinus rhythm in patients with a history of atrial fibrillation<br \/><ul><li>beta-blockers<\/li><li>dronedarone: second-line in patients following cardioversion<\/li><li>amiodarone: particularly if coexisting heart failure <\/li><\/ul><br \/><br \/><h5 class='notes-heading'>Catheter ablation<\/h5><br \/>NICE recommends the use of catheter ablation for those with AF who have not responded to or wish to avoid, antiarrhythmic medication.<br \/><br \/>Technical aspects<br \/><ul><li>the aim is to ablate the faulty electrical pathways that are resulting in atrial fibrillation. This is typically due to <span class=\"concept\" data-cid=\"10663\">aberrant electrical activity between the pulmonary veins and left atrium<\/span><\/li><li>the procedure is performed percutaneously, typically via the groin<\/li><li>both radiofrequency (uses heat generated from medium frequency alternating current) and cryotherapy can be used to ablate the tissue<\/li><\/ul><br \/>Anticoagulation <br \/><ul><li>should be used 4 weeks before and during the procedure<\/li><li>it should be remember that catheter ablation controls the rhythm but does not reduce the stroke risk, even if patients remain in sinus rhythm. Therefore, <span class=\"concept\" data-cid=\"10662\">patients still require anticoagulation as per their CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc score<\/span><ul><li>if score = 0: 2 months anticoagulation recommended<\/li><li>if score > 1: longterm anticoagulation recommended<\/li><\/ul><\/li><\/ul><br \/>Outcome<br \/><ul><li>notable complications include<ul><li>cardiac tamponade<\/li><li>stroke<\/li><li>pulmonary vein stenosis<\/li><\/ul><\/li><li>success rate<ul><li>around 50% of patients experience an early recurrence (within 3 months) of AF that often resolves spontaneously<\/li><li>longer term, after 3 years, around 55% of patients who've had a single procedure remain in sinus rhythm. Of patients who've undergone multiple procedures around 80% are in sinus rhythm<\/li><\/ul><\/li><\/ul>","notes_hash":"e9661ae706ac2fe13caef3b9d80ba0f4","knowledge_graph_node_id_link":1162,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2046\" data-linkid=\"2046\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_2046\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">32<\/span><button type=\"button\" style=\"\" id=\"link_dislike_2046\" data-linkid=\"2046\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_2046\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng196\/chapter\/Recommendations\">2021 Atrial fibrillation guidelines<\/a><\/td><\/tr><\/table><br><br><table style='width:100%'><tr><td>European Society of Cardiology<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_32\" data-linkid=\"32\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_32\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20<\/span><button type=\"button\" style=\"\" id=\"link_dislike_32\" data-linkid=\"32\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_32\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">10<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/academic.oup.com\/eurheartj\/article\/42\/5\/373\/5899003\">2020 Atrial fibrillation guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/J33lfh6w3gI\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/J33lfh6w3gI\" data-description=\"Understanding Atrial Fibrillation\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1688\">Understanding Atrial Fibrillation<\/a><\/td><\/tr><tr><td><span ><small>Zero To Finals - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2869\" data-mediaid=\"2869\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2869\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2869\" data-mediaid=\"2869\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2869\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"1107\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/wxJuP-i9Jx0\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/wxJuP-i9Jx0\" data-description=\"Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications\" data-upvotes=\"6\" data-downvotes=\"4\" data-media=\"1107\">Atrial Fibrillation Overview - ECG, types, pathophysiology, treatment, complications<\/a><\/td><\/tr><tr><td><span ><small>Armando Hasudungan - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1917\" data-mediaid=\"1917\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1917\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1917\" data-mediaid=\"1917\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1917\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"200":{"concept_text":"Atrial fibrillation: rate control - beta blockers preferable to digoxin","concept_percentile":"54"},"10662":{"concept_text":"Patients who've had a catheter ablation for atrial fibrillation still require long-term anticoagulation as per their CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc score ","concept_percentile":"93"},"10829":{"concept_text":"Beta-blockers are contraindicated in patients with asthma when managing atrial fibrillation","concept_percentile":"100"},"11783":{"concept_text":"Acute presentation of atrial fibrillation: if signs of haemodynamic instability (e.g. hypotension, heart failure) --> electrical cardioversion, as per the peri-arrest tachycardia guidelines","concept_percentile":"60"},"11784":{"concept_text":"Acute onset of atrial fibrillation: if \u2265 48 hours or uncertain (e.g. patient not sure when symptoms started) --> rate control","concept_percentile":"89"},"11785":{"concept_text":"Acute onset of atrial fibrillation: if \u2265 48 hours - rate control initially, then if considered for long-term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a minimum of 3 weeks","concept_percentile":"87"}},"category_name":"Cardiovascular","subcategory_name":"Cardiology","comment_count":15},"",[]]